Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | AVB-001 |
Trade Name | |
Synonyms | AVB 001|AVB001 |
Drug Descriptions |
AVB-001 comprises polymer encapsulated epithelial cells engineered to express IL-2, which potentially leads to enhanced antitumor immune response and inhibition of tumor growth (Journal for ImmunoTherapy of Cancer 2022;10). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C192001 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
AVB-001 | AVB-001 | 0 | 1 |